// App-Quantinova.ai

P123 : Biologic dose tapering: a patient perspective

Researchers

Presenter

  • Rayan Rahman

Principal Investigators

  • Celia Beynon

Medical Centers

  • University Hospital of Wales, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Certolizumab pegol

  • Adalimumab

  • Etanercept

  • CHS-0214

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved